IRIS Accounts Production v24.3.0.553 08358524 director 1.2.23 31.1.24 31.1.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh083585242023-01-31083585242024-01-31083585242023-02-012024-01-31083585242022-01-31083585242022-02-012023-01-31083585242023-01-3108358524ns15:EnglandWales2023-02-012024-01-3108358524ns14:PoundSterling2023-02-012024-01-3108358524ns10:Director12023-02-012024-01-3108358524ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3108358524ns10:Micro-entities2023-02-012024-01-3108358524ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3108358524ns10:FullAccounts2023-02-012024-01-3108358524ns5:CurrentFinancialInstruments2024-01-3108358524ns5:CurrentFinancialInstruments2023-01-3108358524ns5:Non-currentFinancialInstruments2024-01-3108358524ns5:Non-currentFinancialInstruments2023-01-3108358524ns10:RegisteredOffice2023-02-012024-01-31083585241ns10:Director12023-01-31083585241ns10:Director12022-01-31083585241ns10:Director12023-02-012024-01-31083585241ns10:Director12022-02-012023-01-31083585241ns10:Director12024-01-31083585241ns10:Director12023-01-31
REGISTERED NUMBER: 08358524 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

Endopath Ltd

Endopath Ltd (Registered number: 08358524)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Balance Sheet 1


Endopath Ltd (Registered number: 08358524)

Balance Sheet
31 January 2024

31.1.24 31.1.23
£    £    £    £   
FIXED ASSETS 24,783 32,956

CURRENT ASSETS 150,695 148,945

CREDITORS
Amounts falling due within one year (59,103 ) (30,962 )
NET CURRENT ASSETS 91,592 117,983
TOTAL ASSETS LESS CURRENT
LIABILITIES

116,375

150,939

CREDITORS
Amounts falling due after more than one
year

36,586

46,382
NET ASSETS 79,789 104,557

CAPITAL AND RESERVES 79,789 104,557

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Endopath Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 08358524

Registered office: 34 Antonine Gate
St. Albans
Hertfordshire
AL3 4JB

The presentation currency of the financial statements is the Pound Sterling (£).


2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2023 - 2 ) .

Endopath Ltd (Registered number: 08358524)

Balance Sheet - continued
31 January 2024

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2024 and 31 January 2023:

31.1.24 31.1.23
£    £   
H Abdellatif
Balance outstanding at start of year 123,172 77,066
Amounts advanced 130,721 126,403
Amounts repaid (126,878 ) (80,297 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 127,015 123,172

Interest is charged on balance over £*10,000 at the HMRC approved rate 2.25% (2022/23: 2.00%).



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 30 October 2024 and were signed by:





H Abdellatif - Director